DMAC Insider Transactions
| Transaction Date (SEC Report ) |
Reporting Name | Relationship | Shrs. Owned | Type | Acq./Disp. | Shrs. Transacted | Price() | Amount() |
|---|---|---|---|---|---|---|---|---|
| 2023-03-01 | Lewis Tanya | director | 26,443 | A-Award | A | 26,443 | 1.77 | 46,804.11 |
| 2023-01-03 | Giuffre Randall Michael | director | 295,355 | A-Award | A | 35,130 | 1.53 | 53,748.90 |
| 2023-01-03 | Burroughs Amy L. | director | 73,288 | A-Award | A | 17,156 | 1.53 | 26,248.68 |
| 2023-01-03 | Semba Charles Pauling | director | 17,156 | A-Award | A | 17,156 | 1.53 | 26,248.68 |
| 2023-01-03 | Pilnik Richard D. | director | 209,882 | A-Award | A | 55,555 | 1.53 | 84,999.15 |
| 2022-12-09 | Giuffre Randall Michael | director | 260,225 | P-Purchase | A | 37,079 | 1.43 | 53,022.97 |
| 2022-12-08 | Giuffre Randall Michael | director | 223,146 | P-Purchase | A | 20,000 | 1.40 | 28,000.00 |
| 2022-12-07 | Giuffre Randall Michael | director | 203,146 | P-Purchase | A | 22,574 | 1.40 | 31,603.60 |
| 2022-12-06 | Giuffre Randall Michael | director | 180,572 | P-Purchase | A | 2,300 | 1.35 | 3,105.00 |
| 2022-12-05 | Pilnik Richard D. | director | 154,327 | P-Purchase | A | 35,000 | 1.39 | 48,492.50 |
| 2022-12-02 | Von Koch Thomas | 10 percent owner | 2,855,847 | P-Purchase | A | 2,855,847 | 1.24 | 3,526,971.05 |
| 2022-12-02 | Von Koch Thomas | 10 percent owner | 0 | S-Sale | D | 2,855,847 | 1.24 | 3,526,971.05 |
| 2022-12-01 | Giuffre Randall Michael | director | 178,272 | P-Purchase | A | 819 | 1.19 | 974.61 |
| 2022-12-01 | Giuffre Randall Michael | director | 177,453 | P-Purchase | A | 46,133 | 1.20 | 55,359.60 |
| 2022-11-30 | Giuffre Randall Michael | director | 131,320 | P-Purchase | A | 2,970 | 1.19 | 3,534.30 |
| 2022-11-29 | Giuffre Randall Michael | director | 128,350 | P-Purchase | A | 18,125 | 1.19 | 21,568.75 |
| 2022-11-16 | Pauls Dietrich John | director, officer: President and CEO | 55,804 | P-Purchase | A | 20,000 | 1.21 | 24,200.00 |
| 2022-09-13 | Daves Julie VanOrsdel | officer: SVP Clinical Development Oper. | 140,000 | A-Award | A | 140,000 | 1.47 | 205,800.00 |
| 2022-07-08 | Von Koch Thomas | 10 percent owner | 2,855,827 | P-Purchase | A | 207,974 | 1.33 | 275,898.31 |
| 2022-06-01 | Pauls Dietrich John | director, officer: President and CEO | 177,000 | A-Award | A | 177,000 | 2.45 | 433,650.00 |
| 2022-06-01 | Kellen Scott | officer: CFO and Secretary | 60,000 | A-Award | A | 60,000 | 2.45 | 147,000.00 |
| 2022-06-01 | Burroughs Amy L. | director | 13,222 | A-Award | A | 13,222 | 2.45 | 32,393.90 |
| 2022-06-01 | Giuffre Randall Michael | director | 13,222 | A-Award | A | 13,222 | 2.45 | 32,393.90 |
| 2022-06-01 | Parsons James T. | director | 13,222 | A-Award | A | 13,222 | 2.45 | 32,393.90 |
| 2022-06-01 | Pilnik Richard D. | director | 18,510 | A-Award | A | 18,510 | 2.45 | 45,349.50 |
| 2022-06-01 | Semba Charles Pauling | director | 13,222 | A-Award | A | 13,222 | 2.45 | 32,393.90 |
| 2022-02-01 | Cundari Dominic R | officer: Chief Commercial Officer | 40,000 | A-Award | A | 40,000 | 2.90 | 116,000.00 |
| 2022-02-01 | Cundari Dominic R | officer: Chief Commercial Officer | 125,000 | A-Award | A | 125,000 | 2.90 | 362,500.00 |
| 2022-01-03 | Gruis Kirsten L | officer: Chief Medical Officer | 160,000 | A-Award | A | 160,000 | 3.88 | 620,800.00 |
| 2022-01-03 | Parsons James T. | director | 38,509 | A-Award | A | 16,773 | 3.58 | 60,047.34 |
| 2022-01-03 | Pilnik Richard D. | director | 119,327 | A-Award | A | 23,762 | 3.58 | 85,067.96 |
| 2022-01-03 | Burroughs Amy L. | director | 56,132 | A-Award | A | 11,182 | 3.58 | 40,031.56 |
| 2022-01-03 | Giuffre Randall Michael | director | 110,225 | A-Award | A | 15,026 | 3.58 | 53,793.08 |
| 2021-09-15 | ALCORN HARRY W JR | officer: SVP, Clinical Operations | 43,582 | P-Purchase | A | 15,000 | 3.80 | 56,959.50 |
| 2021-08-16 | Kellen Scott | officer: CFO and Secretary | 22,290 | P-Purchase | A | 10,000 | 3.15 | 31,463.00 |
| 2021-08-16 | ALCORN HARRY W JR | officer: Chief Medical Officer | 28,260 | P-Purchase | A | 20,000 | 3.09 | 61,844.00 |
| 2021-08-16 | ALCORN HARRY W JR | officer: Chief Medical Officer | 28,582 | P-Purchase | A | 322 | 3.06 | 984.93 |
| 2021-08-16 | Pauls Dietrich John | director, officer: President and CEO | 35,804 | P-Purchase | A | 5,000 | 3.14 | 15,700.00 |
| 2021-08-16 | ALCORN HARRY W JR | officer: Chief Medical Officer | 399 | P-Purchase | A | 399 | 3.07 | 1,224.93 |
| 2021-08-16 | Burroughs Amy L. | director | 44,950 | P-Purchase | A | 44,950 | 3.15 | 141,592.50 |
| 2021-08-16 | Pilnik Richard D. | director | 83,065 | P-Purchase | A | 2,500 | 3.21 | 8,031.50 |
| 2021-08-16 | Pilnik Richard D. | director | 95,565 | P-Purchase | A | 12,500 | 3.28 | 41,032.50 |
| 2021-07-28 | Kellen Scott | officer: CFO and Secretary | 60,000 | A-Award | A | 60,000 | 5.00 | 300,000.00 |
| 2021-07-28 | ALCORN HARRY W JR | officer: Chief Medical Officer | 60,000 | A-Award | A | 60,000 | 5.00 | 300,000.00 |
| 2021-07-28 | Gilman Sydney A. | officer: VP, Regulatory Affairs | 25,000 | A-Award | A | 25,000 | 5.00 | 125,000.00 |
| 2021-07-28 | Pauls Dietrich John | director, officer: President and CEO | 175,000 | A-Award | A | 175,000 | 5.00 | 875,000.00 |
| 2021-07-15 | Giuffre Randall Michael | director | 9,393 | A-Award | A | 9,393 | 3.64 | 34,190.52 |
| 2021-07-15 | Burroughs Amy L. | director | 18,786 | A-Award | A | 18,786 | 3.64 | 68,381.04 |
| 2021-07-15 | Semba Charles Pauling | director | 18,786 | A-Award | A | 18,786 | 3.64 | 68,381.04 |
| 2021-07-15 | Parsons James T. | director | 9,393 | A-Award | A | 9,393 | 3.64 | 34,190.52 |
| 2021-07-15 | Pilnik Richard D. | director | 13,150 | A-Award | A | 13,150 | 3.64 | 47,866.00 |
| 2021-01-01 | Giuffre Randall Michael | director | 116,029 | A-Award | A | 7,441 | 8.23 | 61,239.43 |
| 2021-01-01 | Pilnik Richard D. | director | 80,565 | A-Award | A | 9,719 | 8.23 | 79,987.37 |
| 2021-01-01 | Parsons James T. | director | 21,947 | A-Award | A | 7,745 | 8.23 | 63,741.35 |
| 2020-12-04 | Pilnik Richard D. | director | 65,846 | P-Purchase | A | 5,000 | 5.24 | 26,200.00 |
| 2020-12-04 | Pilnik Richard D. | director | 70,846 | P-Purchase | A | 5,000 | 5.24 | 26,200.00 |
| 2020-11-20 | Giuffre Randall Michael | director | 108,588 | P-Purchase | A | 15,000 | 4.26 | 63,912.00 |
| 2020-11-09 | Kellen Scott | officer: CFO and Secretary | 12,290 | P-Purchase | A | 2,000 | 4.19 | 8,386.60 |
| 2020-06-01 | Parsons James T. | director | 14,202 | A-Award | A | 8,102 | 4.59 | 37,188.18 |
| 2020-06-01 | Parsons James T. | director | 13,306 | A-Award | A | 13,306 | 4.64 | 61,739.84 |
| 2020-06-01 | Giuffre Randall Michael | director | 93,588 | A-Award | A | 7,784 | 4.59 | 35,728.56 |
| 2020-06-01 | Giuffre Randall Michael | director | 13,306 | A-Award | A | 13,306 | 4.64 | 61,739.84 |
| 2020-06-01 | Pauls Dietrich John | director, officer: President and CEO | 56,000 | A-Award | A | 56,000 | 4.64 | 259,840.00 |
| 2020-06-01 | Kellen Scott | officer: CFO and Secretary | 35,000 | A-Award | A | 35,000 | 0.00 | 0.00 |
| 2020-06-01 | Gilman Sydney A. | officer: VP, Regulatory Affairs | 17,500 | A-Award | A | 17,500 | 4.64 | 81,200.00 |
| 2020-06-01 | Pilnik Richard D. | director | 60,846 | A-Award | A | 10,168 | 0.00 | 0.00 |
| 2020-06-01 | Pilnik Richard D. | director | 19,220 | A-Award | A | 19,220 | 0.00 | 0.00 |
| 2020-06-01 | ALCORN HARRY W JR | officer: Chief Medical Officer | 35,000 | A-Award | A | 35,000 | 4.64 | 162,400.00 |
| 2019-11-01 | Gilman Sydney A. | officer: VP, Regulatory Affairs | 50,000 | A-Award | A | 50,000 | 4.00 | 200,000.00 |
| 2019-08-19 | Kellen Scott | officer: CFO and Secretary | 10,290 | P-Purchase | A | 3,000 | 2.43 | 7,290.00 |
| 2019-08-16 | Pauls Dietrich John | director, officer: President and CEO | 30,804 | P-Purchase | A | 1,000 | 2.68 | 2,676.90 |
| 2019-08-16 | Pilnik Richard D. | director | 50,678 | P-Purchase | A | 7,840 | 2.56 | 20,039.04 |
| 2019-08-16 | ALCORN HARRY W JR | officer: Chief Medical Officer | 8,260 | P-Purchase | A | 7,260 | 2.67 | 19,365.32 |
| 2019-06-24 | ALCORN HARRY W JR | officer: Chief Medical Officer | 125,000 | A-Award | A | 125,000 | 4.60 | 575,000.00 |
| 2019-06-24 | Giuffre Randall Michael | director | 12,950 | A-Award | A | 12,950 | 4.60 | 59,570.00 |
| 2019-06-24 | Kellen Scott | officer: CFO and Secretary | 99,750 | A-Award | A | 99,750 | 4.60 | 458,850.00 |
| 2019-06-24 | Parsons James T. | director | 12,950 | A-Award | A | 12,950 | 4.60 | 59,570.00 |
| 2019-06-24 | Pauls Dietrich John | director, officer: President and CEO | 264,000 | A-Award | A | 264,000 | 4.60 | 1,214,400.00 |
| 2019-06-24 | Pilnik Richard D. | director | 18,700 | A-Award | A | 18,700 | 4.60 | 86,020.00 |
| 2019-06-24 | Verdoorn Todd A. | officer: Chief Scientific Officer | 71,025 | A-Award | A | 71,025 | 4.60 | 326,715.00 |
| 2019-06-24 | Xiao Zhenyu | director | 12,950 | A-Award | A | 12,950 | 4.60 | 59,570.00 |
| 2019-05-31 | Pilnik Richard D. | director | 42,838 | P-Purchase | A | 19,000 | 2.80 | 53,200.00 |
| 2019-05-24 | Kellen Scott | officer: CFO and Secretary | 7,290 | P-Purchase | A | 4,000 | 0.00 | 0.00 |
| 2019-03-28 | ALCORN HARRY W JR | officer: Chief Medical Officer | 1,000 | G-Gift | D | 150 | 0.00 | 0.00 |
| 2019-03-27 | ALCORN HARRY W JR | officer: Chief Medical Officer | 1,150 | P-Purchase | A | 150 | 0.00 | 0.00 |
| 2018-12-11 | Giuffre Randall Michael | director | 85,804 | P-Purchase | A | 11,250 | 4.00 | 45,000.00 |
| 2018-12-11 | ALCORN HARRY W JR | officer: Chief Medical Officer | 1,000 | P-Purchase | A | 1,000 | 4.00 | 4,000.00 |
| 2018-12-11 | Verdoorn Todd A. | officer: Chief Scientific Officer | 2,000 | P-Purchase | A | 1,000 | 4.00 | 4,000.00 |
| 2018-12-11 | Kellen Scott | officer: CFO and Secretary | 3,290 | P-Purchase | A | 1,250 | 4.00 | 5,000.00 |
| 2018-12-11 | Pauls Dietrich John | director, officer: President and CEO | 29,804 | P-Purchase | A | 5,000 | 4.00 | 20,000.00 |
| 2018-12-11 | Pilnik Richard D. | director | 23,838 | P-Purchase | A | 6,250 | 4.00 | 25,000.00 |
| 2018-12-11 | Xiao Zhenyu | director | 7,100 | P-Purchase | A | 3,250 | 4.00 | 13,000.00 |
| 2018-12-11 | Parsons James T. | director | 6,100 | P-Purchase | A | 2,250 | 4.00 | 9,000.00 |
Disclaimer: The data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by our third party API www.financialmodellingprep.com, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore, Discounting Cash Flows Group doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Discounting Cash Flows Group or anyone involved with Discounting Cash Flows Group will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.